Xtant Medical
-
Financial
Xtant Medical Announces Record Third Quarter Revenue of $25 Million
Raises 2023 Annual Revenue Guidance to $88 Million – $91 Million BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) — Xtant…
Read More » -
Spine
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical
Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth BELGRADE, Mont., Oct. 23, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings,…
Read More » -
Biologics
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business
BELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Second Quarter Revenue Growth of 32%
Raises 2023 Annual Revenue Guidance to $75 Million – $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) — Xtant…
Read More » -
Biologics
Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business
Acquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings,…
Read More » -
Financial
Xtant Medical Announces Closing of $15 Million Private Placement
BELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces $15 Million Private Placement
BELGRADE, Mont., July 03, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors
BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance
Initiates Annual Revenue Guidance of $73 Million – $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE…
Read More » -
Financial
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
BELGRADE, Mont., March 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Spine
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital…
Read More » -
Spine
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
BELGRADE, Mont., Jan. 09, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Third Quarter 2022 Financial Results
BELGRADE, Mont., Nov. 03, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment
BELGRADE, Mont., Oct. 11, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More »